American Journal of Physiology-Heart and Circulatory Physiology · 2010 · 41 citations · 53 references
Life SciencesBiochemistryPharmacologyCell SignalingInflammationSignal TransductionAcid-base RegulationCardiovascular Molecular PhysiologyG Protein-coupled Receptor SignalingInflammatory SignalingReceptor RegulationAtherosclerosis Molecular MechanismsAtherosclerotic Lipid AccumulationCyclooxygenase-2 PathwayG Protein-coupled Receptor RegulationPlasminogen ActivatorsProstaglandin SignalingVascular Smooth Muscle Cell PhysiologyVascular Smooth Muscle Regulation
Atherosclerosis is a chronic inflammation disease characterized by acidic micromilieu and the accumulation of numerous bioactive lipid mediators, such as lysophosphatidic acid (LPA) and prostaglandins, in the atherosclerotic lesion. Chronic acidification induced various effects on vascular smooth muscle cells, but the molecular mechanisms underlying these effects remain unknown. In this study, we examine the role of proton-sensing ovarian cancer G protein-coupled receptor 1 (OGR1) in extracellular acidification-induced regulation of cyclooxygenase (COX)-2 induction, PGI(2) production, MAPK phosphatase (MKP)-1 expression, and plasminogen activator inhibitor (PAI)-1 expression and proliferation in human aortic smooth muscle cells (AoSMCs). Experiments with knockdown with small interfering RNA specific to OGR1 and specific inhibitors for G proteins showed that acidification-induced COX-2 expression, PGI(2) production, and MKP-1 expression, but not PAI-1 expression and inhibition of proliferation, were dependent on OGR1 and mainly mediated by G(q/11) protein. LPA remarkably enhanced, through the LPA(1) receptor/G(i) protein, the OGR1-mediated vascular actions to acidic pH. In conclusion, acidic pH-induced vascular actions of AoSMCs can be dissected to OGR1-dependent and -independent pathways: COX-2 expression, PGI(2) production, and MKP-1 expression are mediated by OGR1, but PAI-1 expression and inhibition of proliferation are not. LPA, which is usually thought to be a proatherogenic lipid mediator, may exert antiatherogenic actions under acidic micromilieu through cross-talk between LPA(1)/G(i) protein and OGR1/G(q/11) protein.
53
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Bart Staels, Wolfgang Köenig, Régine Merval et al. · Nature · 1998 · 1.1K citations
The effects of extracellular pH on immune function
Anne L. Lardner · Journal of Leukocyte Biology · 2001 · 870 citations
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A <sub>2</sub>
Yan Cheng, Sandra Austin, Bianca Rocca et al. · Science · 2002 · 788 citations
Medicine, Cardiology, Pharmacology +17
Proton-sensing G-protein-coupled receptors
Marie‐Gabrielle Ludwig, M. Vanek, Danilo Guerini et al. · Nature · 2003 · 742 citations
COX-2-Derived Prostacyclin Confers Atheroprotection on Female Mice
Karine Egan, John A. Lawson, Susanne Fries et al. · Science · 2004 · 426 citations